CStone Pharmaceuticals (CSPHF) Financials

CSPHF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 194.3 million 95.4 million
June 30, 2025 166.4 million 122.4 million
Dec. 31, 2024 190.9 million 141.1 million
June 30, 2024 210.8 million 146.5 million

CSPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 ? -212866
Dec. 31, 2024 -21.4 million -1.0 million
June 30, 2024 -25.8 million 640034

CSPHF Net Income

No data available :(

CSPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 131.4 million 22.4 million 61347
June 30, 2025 91.1 million 23.6 million 3.9 million
Dec. 31, 2024 92.2 million 35.3 million 5.2 million
June 30, 2024 118.0 million 31.4 million 3.9 million

CSPHF Shares Outstanding

No data available :(

CSPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 29.0 million 12.7 million -
June 30, 2025 - 7.3 million 5.5 million 2.5 million
Dec. 31, 2024 - 9.4 million 14.0 million 9.7 million
June 30, 2024 - 9.1 million 15.1 million 8.6 million

CSPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 30.9 million 11.1 million
June 30, 2025 3.5 million 9.9 million
Dec. 31, 2024 21.0 million 11.6 million
June 30, 2024 35.0 million 11.3 million

CSPHF

Price: $0.60

52 week price:
0.52
1.01

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.1 billion

Links: